Nicotine pouches deliver nicotine doses that vastly exceed the acute reference dose, posing significant cardiovascular health risks such as elevated heart rate.
Orally consumed nicotine pouches that contain no tobacco are marketed as a less harmful alternative to tobacco products. This study aims to assess nicotine in pouches and potential risks for health damage. 31 samples of nicotine pouches were collected and analyzed. The median nicotine uptake from single pouches was calculated to be 65 µg/kg bw. Consumption of more than one pouch per day would lead to a strikingly higher nicotine dose over the day. Health effects after nicotine exposure are, among others, cardiovascular effects. An acute reference dose (ARfD) of 0.8 µg/kg bw was proposed for risk assessment purposes based on an observed increased heart rate in a human study after acute nicotine uptake. The ARfD was exceeded by at least 20-fold, even when considering the consumption of a single pouch with the lowest detected nicotine level. With higher nicotine contents in pouches or with an increasing number of pouches per day, vast ARfD exceedances are possible. Therefore, a clinically relevant elevation of heart rate is very likely to occur in consumers after acute consumption of nicotine pouches. • Nicotine pouches are marketed as “safe” alternative to tobacco products. • However, nicotine may cause health damage, e. g. by cardio-vascular effects. • Nicotine in pouches was determined and resulting health risks assessed. • All investigated pouches pose health risks.
Reimann et al. (Mon,) studied this question.